Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$517K Sell
1,746
-77
-4% -$20.8K 0.07% 169
2019
Q3
$453K Buy
1,823
+598
+49% +$135K 0.06% 174
2019
Q2
$255K Buy
+1,225
New +$244K 0.04% 230
2014
Q4
Sell
-3,778
Closed -$373K 293
2014
Q3
$373K Sell
3,778
-325
-8% -$30.6K 0.07% 206
2014
Q2
$383K Sell
4,103
-1,386
-25% -$120K 0.07% 207
2014
Q1
$512K Buy
5,489
+353
+7% +$31.4K 0.11% 170
2013
Q4
$481K Sell
5,136
-567
-10% -$52.6K 0.11% 188
2013
Q3
$563K Sell
5,703
-12,491
-69% -$1.12M 0.14% 164
2013
Q2
$1.44M Buy
+18,194
New +$1.38M 0.08% 161

Other funds holding ASML

CIBC Bank USA's ASML Position: Q4 2019 in Review

CIBC Bank USA reduced its ASML (ASML) stake by 4.2% in Q4 2019, selling an estimated $20.8K and leaving 1,746 shares worth $517K. The position accounts for 0.07% of the portfolio, ranked #169.

CIBC Bank USA first reported a position in ASML in Q2 2013 and has held it in 9 quarters since. The position peaked at $1.44M in Q2 2013. 470 funds tracked by Wall St. Rank hold ASML as of Q4 2019.

  • CIBC Bank USA held 1,746 shares of ASML worth $517K as of Q4 2019.
  • CIBC Bank USA sold 77 ASML shares in Q4 2019, an estimated $20.8K.
  • ASML made up 0.07% of CIBC Bank USA's portfolio in Q4 2019, its #169 holding.
  • CIBC Bank USA first reported a position in ASML in Q2 2013 and has held it in 9 quarters since.
  • CIBC Bank USA's ASML position peaked at $1.44M in Q2 2013.
  • 470 funds tracked by Wall St. Rank held ASML as of Q4 2019.

Based on CIBC Bank USA's 13F filing for Q4 2019, filed 29 Jan 2020.